STOCK TITAN

Iovance CRO has 9,766 RSUs vest into shares

IOVA’s Chief Regulatory Officer reports RSU vesting with shares withheld for taxes, not sold on the open market.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported that Chief Regulatory Officer Raj K. Puri had restricted stock units vest on September 8, 2026, converting 9,766 RSUs into an equal number of common shares. Of these, 4,478 shares were withheld by the company at $8.70 per share to satisfy mandatory tax withholding requirements, which the company notes was not an open-market sale. Following the RSU exercise, 58,599 RSUs from the March 5, 2025 grant remain outstanding and will vest in equal quarterly installments, and no Rule 10b5-1 trading plan is reported.

Positive

  • None.

Negative

  • None.
Insider Puri Raj K.
Role Chief Regulatory Officer
Type Security Shares Price Value
Exercise Restricted Stock Units F4, F5, F6 9,766 $0.00 $0.00
Exercise Common Stock F1 9,766 $0.00 $0.00
Tax Withholding Common Stock F2, F3 4,478 $8.70 $39K
Holdings After Transaction: Restricted Stock Units — 58,599 contracts (Direct); Common Stock — 256,364 shares (Direct)
Footnotes (6)
  1. F1. Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
  2. F2. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
  3. F3. Represents the common stock remaining after deducting the common stock withheld for taxes.
  4. F4. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  5. F5. The remaining RSUs will vest in equal quarterly installments.
  6. F6. Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.
RSUs vested and converted 9,766 units/shares Restricted stock units vested and converted into common stock on September 8, 2026
Shares withheld for taxes 4,478 shares Common shares withheld by issuer to satisfy mandatory tax withholding upon RSU vesting
Tax withholding price $8.70 per share Value used for shares withheld to satisfy tax withholding requirements
Remaining RSUs from March 5, 2025 grant 58,599 units Unvested RSUs still outstanding from the March 5, 2025 grant after this vesting event
Restricted Stock Units financial
"Represents such shares underlying the restricted stock units (RSUs) which vested"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
mandatory tax withholding requirements financial
"shares withheld by the Issuer to satisfy the mandatory tax withholding requirements"
contingent right financial
"Each RSU represents a contingent right to receive one share"
Rule 10b5-1 regulatory
"No Rule 10b5-1 trading plan is reported for these transactions"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IOVA report for Chief Regulatory Officer Raj K. Puri?

IOVA reported that Raj K. Puri had 9,766 restricted stock units vest on September 8, 2026, converting into the same number of common shares, with a portion of those shares withheld to cover mandatory tax withholding requirements.

How many IOVA shares were withheld for taxes in this Form 4 filing?

The filing shows 4,478 shares of IOVA common stock were withheld by the issuer at $8.70 per share to satisfy mandatory tax withholding requirements upon RSU vesting. The company states this was not an open market sale of securities.

Did the IOVA insider sell any shares on the open market in this Form 4?

No. The filing states that the 4,478 shares reported with code F were withheld by the issuer to satisfy tax withholding requirements and explicitly notes that this is not an open market sale of IOVA securities.

How many IOVA restricted stock units does Raj K. Puri still hold from the March 5, 2025 grant?

After the reported vesting, the Form 4 indicates that 58,599 RSUs from the March 5, 2025 grant remain outstanding. The footnotes add that this figure does not include any other RSUs held by the reporting person.

What is the vesting schedule for Raj K. Puri’s remaining IOVA RSUs?

The filing states that the remaining RSUs will vest in equal quarterly installments. This schedule applies to the unvested portion of the RSUs referenced, following the September 8, 2026 vesting event reported in the Form 4.

Was a Rule 10b5-1 trading plan involved in the IOVA Form 4 transactions?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not marked, and the footnotes do not reference any trading plan, so the reported RSU vesting and related tax withholding are not identified as pursuant to a Rule 10b5-1 plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Puri Raj K.

(Last)(First)(Middle)
C/O IOVANCE BIOTHERAPEUTICS, INC.
825 INDUSTRIAL ROAD, SUITE 100

(Street)
SAN CARLOS CALIFORNIA 94070

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
IOVANCE BIOTHERAPEUTICS, INC. [ IOVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Regulatory Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)09/08/2026M9,766A$0260,842D
Common Stock(2)09/08/2026F4,478D$8.7256,364(3)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(4)09/08/2026M9,766 (5) (5)Common stock9,766$0.0058,599(6)D
Explanation of Responses:
1. Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
2. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
3. Represents the common stock remaining after deducting the common stock withheld for taxes.
4. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
5. The remaining RSUs will vest in equal quarterly installments.
6. Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.
/s/ Raj K. Puri09/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading